Received Jan 7, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | 22289 | OT |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | 33CM4 | OT |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | Y018677 | OT / LL |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | LN4932 | OT |
No adverse event; Improper storage of product in use; This spontaneous report was received from a nurse and refers to a 17-month-old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies, or concomitant therapies was provided. On 14-Oct-2025, the patient was vaccinated with an improperly stored dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PEDVAX HIB), administered by intramuscular route in the left thigh (dose not reported, lot number Y018677, expiration date established on 10-Apr-2027) for prophylaxis, with a dose of Diphtheria vaccine toxoid;Pertussis vaccine acellular;Tetanus vaccine toxoid (DTAP) administered by intramuscular route (dose and indication not reported, lot number 22289, expiration date reported as 09-Jul-2026), with Pneumococcal vaccine conj 20v (CRM197) (PREVENAR 20) administered by intramuscular route (dose and indication not reported lot number LN4932, expiration date not reported) and with a dose of Influenza vaccine (FLU) administered by intramuscular route (dose and indication not reported, lot number 33CM4, expiration date not reported). No adverse event was reported.